| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 36 | 2022 | 736 | 3.100 |
Why?
|
| Lymphopoiesis | 12 | 2022 | 48 | 2.760 |
Why?
|
| Bone Marrow Cells | 22 | 2021 | 259 | 2.160 |
Why?
|
| Precursor Cells, B-Lymphoid | 5 | 2016 | 27 | 1.930 |
Why?
|
| Hematopoietic Stem Cells | 23 | 2022 | 299 | 1.880 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 8 | 2022 | 131 | 1.800 |
Why?
|
| Cell Lineage | 22 | 2016 | 291 | 1.730 |
Why?
|
| Cell Differentiation | 25 | 2022 | 1513 | 1.360 |
Why?
|
| Homeodomain Proteins | 8 | 2016 | 553 | 1.340 |
Why?
|
| Multipotent Stem Cells | 3 | 2014 | 19 | 1.000 |
Why?
|
| Lymphoid Progenitor Cells | 3 | 2013 | 16 | 0.940 |
Why?
|
| Flow Cytometry | 6 | 2021 | 691 | 0.910 |
Why?
|
| Immunity, Humoral | 1 | 2022 | 66 | 0.800 |
Why?
|
| Dendritic Cells | 3 | 2013 | 436 | 0.790 |
Why?
|
| Hematopoiesis | 15 | 2016 | 164 | 0.750 |
Why?
|
| Bone Marrow | 11 | 2018 | 444 | 0.730 |
Why?
|
| Transcription Factors | 8 | 2021 | 1645 | 0.700 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2018 | 157 | 0.660 |
Why?
|
| Mice | 49 | 2022 | 11700 | 0.640 |
Why?
|
| Killer Cells, Natural | 3 | 2018 | 274 | 0.620 |
Why?
|
| Mice, Knockout | 11 | 2016 | 1987 | 0.570 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 1 | 2016 | 10 | 0.560 |
Why?
|
| Estrogens | 6 | 2013 | 201 | 0.560 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2016 | 5 | 0.540 |
Why?
|
| Animals | 57 | 2022 | 27203 | 0.540 |
Why?
|
| Mice, Inbred C57BL | 14 | 2016 | 3198 | 0.510 |
Why?
|
| Cell Proliferation | 5 | 2021 | 1642 | 0.500 |
Why?
|
| Immune System | 1 | 2016 | 97 | 0.490 |
Why?
|
| B-Lymphocyte Subsets | 4 | 2010 | 40 | 0.450 |
Why?
|
| Trans-Activators | 7 | 2018 | 443 | 0.450 |
Why?
|
| Signal Transduction | 8 | 2014 | 3366 | 0.390 |
Why?
|
| Antigens, CD | 8 | 2013 | 465 | 0.380 |
Why?
|
| Cell Survival | 6 | 2016 | 980 | 0.360 |
Why?
|
| Transcription, Genetic | 5 | 2013 | 1156 | 0.350 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2008 | 657 | 0.350 |
Why?
|
| Genes, Immunoglobulin | 4 | 2005 | 111 | 0.350 |
Why?
|
| Cells, Cultured | 13 | 2021 | 2874 | 0.340 |
Why?
|
| Membrane Proteins | 5 | 2013 | 1214 | 0.330 |
Why?
|
| Lymphocytes | 6 | 2005 | 470 | 0.320 |
Why?
|
| Mice, Transgenic | 9 | 2021 | 1570 | 0.320 |
Why?
|
| Receptors, Interleukin-7 | 4 | 2013 | 28 | 0.300 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2018 | 661 | 0.280 |
Why?
|
| Antigens, CD34 | 2 | 2018 | 158 | 0.260 |
Why?
|
| Pregnancy, Animal | 3 | 1994 | 58 | 0.260 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 2 | 2005 | 37 | 0.260 |
Why?
|
| Apoptosis | 3 | 2011 | 1716 | 0.260 |
Why?
|
| DNA-Binding Proteins | 9 | 2008 | 1239 | 0.250 |
Why?
|
| Transgenes | 2 | 2016 | 182 | 0.240 |
Why?
|
| Antigens, Ly | 2 | 2013 | 37 | 0.230 |
Why?
|
| Interleukin-7 | 6 | 2007 | 41 | 0.210 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2021 | 10 | 0.200 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2021 | 37 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2014 | 196 | 0.190 |
Why?
|
| Ligands | 1 | 2022 | 440 | 0.190 |
Why?
|
| Stem Cells | 4 | 2014 | 369 | 0.180 |
Why?
|
| Leukocyte Common Antigens | 3 | 2013 | 46 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 13 | 2003 | 1086 | 0.170 |
Why?
|
| Antigens, CD19 | 3 | 2013 | 41 | 0.170 |
Why?
|
| Gene Expression Regulation | 2 | 2005 | 1976 | 0.170 |
Why?
|
| GATA2 Transcription Factor | 1 | 2018 | 14 | 0.160 |
Why?
|
| GATA1 Transcription Factor | 1 | 2018 | 18 | 0.160 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 155 | 0.150 |
Why?
|
| Membrane Glycoproteins | 5 | 2013 | 431 | 0.150 |
Why?
|
| Cellular Senescence | 2 | 2016 | 103 | 0.150 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2016 | 2 | 0.150 |
Why?
|
| GPI-Linked Proteins | 2 | 2013 | 51 | 0.140 |
Why?
|
| Growth and Development | 1 | 2016 | 12 | 0.140 |
Why?
|
| Lymphocyte Count | 2 | 2013 | 98 | 0.140 |
Why?
|
| Epistasis, Genetic | 1 | 2016 | 89 | 0.140 |
Why?
|
| Stress, Physiological | 1 | 2016 | 231 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 699 | 0.120 |
Why?
|
| Progesterone | 1 | 1994 | 110 | 0.120 |
Why?
|
| Humans | 20 | 2021 | 88482 | 0.120 |
Why?
|
| Janus Kinase 2 | 1 | 2014 | 60 | 0.120 |
Why?
|
| CD11c Antigen | 1 | 2013 | 13 | 0.120 |
Why?
|
| Gene Rearrangement | 3 | 2005 | 172 | 0.110 |
Why?
|
| Granulocyte-Macrophage Progenitor Cells | 1 | 2013 | 1 | 0.110 |
Why?
|
| Signaling Lymphocytic Activation Molecule Family Member 1 | 1 | 2013 | 4 | 0.110 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 1 | 2013 | 5 | 0.110 |
Why?
|
| Receptors, Complement | 1 | 2013 | 46 | 0.110 |
Why?
|
| PAX5 Transcription Factor | 4 | 2008 | 32 | 0.110 |
Why?
|
| Gene Expression | 6 | 2012 | 1311 | 0.110 |
Why?
|
| Models, Immunological | 1 | 2013 | 81 | 0.110 |
Why?
|
| Repressor Proteins | 2 | 2008 | 419 | 0.100 |
Why?
|
| Arthritis | 1 | 2012 | 47 | 0.100 |
Why?
|
| B7-2 Antigen | 1 | 2012 | 40 | 0.100 |
Why?
|
| Stromal Cells | 6 | 2003 | 150 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2003 | 182 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2013 | 289 | 0.100 |
Why?
|
| Adipocytes | 2 | 2003 | 163 | 0.100 |
Why?
|
| Lymphocyte Subsets | 3 | 2013 | 66 | 0.100 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2011 | 8 | 0.100 |
Why?
|
| Female | 18 | 2021 | 45687 | 0.100 |
Why?
|
| Immune Tolerance | 1 | 1993 | 338 | 0.100 |
Why?
|
| Cell Line | 6 | 2010 | 2498 | 0.100 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2011 | 37 | 0.100 |
Why?
|
| Gonadal Steroid Hormones | 4 | 2012 | 50 | 0.100 |
Why?
|
| Male | 15 | 2021 | 41953 | 0.090 |
Why?
|
| Homeostasis | 1 | 2013 | 408 | 0.090 |
Why?
|
| Cell Count | 1 | 2011 | 198 | 0.090 |
Why?
|
| Co-Repressor Proteins | 1 | 2010 | 18 | 0.090 |
Why?
|
| Haploinsufficiency | 1 | 2011 | 63 | 0.090 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 6713 | 0.090 |
Why?
|
| Testosterone Propionate | 1 | 2010 | 1 | 0.090 |
Why?
|
| Adult Stem Cells | 1 | 2010 | 29 | 0.090 |
Why?
|
| Periaqueductal Gray | 1 | 2010 | 11 | 0.090 |
Why?
|
| Gene Silencing | 1 | 2010 | 178 | 0.090 |
Why?
|
| Spleen | 4 | 2021 | 431 | 0.090 |
Why?
|
| Immunoglobulin Variable Region | 3 | 2005 | 109 | 0.090 |
Why?
|
| Heterozygote | 1 | 2011 | 372 | 0.090 |
Why?
|
| Narcotics | 1 | 2010 | 69 | 0.090 |
Why?
|
| Mice, Mutant Strains | 3 | 2004 | 231 | 0.090 |
Why?
|
| Proteins | 3 | 2005 | 786 | 0.080 |
Why?
|
| Androgens | 1 | 2010 | 175 | 0.080 |
Why?
|
| Morphine | 1 | 2010 | 130 | 0.080 |
Why?
|
| Lymphocyte Activation | 2 | 2009 | 745 | 0.080 |
Why?
|
| RNA, Messenger | 8 | 2010 | 2008 | 0.080 |
Why?
|
| Pregnancy | 7 | 2010 | 2995 | 0.080 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 2005 | 131 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2005 | 891 | 0.070 |
Why?
|
| Cell Division | 5 | 2002 | 696 | 0.070 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2003 | 36 | 0.070 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2004 | 114 | 0.070 |
Why?
|
| Milk Proteins | 1 | 2005 | 24 | 0.070 |
Why?
|
| Genes, Regulator | 1 | 2005 | 65 | 0.060 |
Why?
|
| Genetic Complementation Test | 1 | 2004 | 97 | 0.060 |
Why?
|
| Thymus Gland | 5 | 2002 | 197 | 0.060 |
Why?
|
| Retroviridae | 1 | 2004 | 79 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 4 | 1996 | 1401 | 0.060 |
Why?
|
| Aged | 3 | 2018 | 18904 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2005 | 162 | 0.060 |
Why?
|
| Lymphocyte Depletion | 2 | 1994 | 98 | 0.060 |
Why?
|
| Myeloid Cells | 3 | 2012 | 100 | 0.060 |
Why?
|
| Cell Nucleus | 2 | 2005 | 594 | 0.060 |
Why?
|
| Cytokines | 3 | 2000 | 801 | 0.060 |
Why?
|
| Dexamethasone | 1 | 2005 | 344 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2000 | 324 | 0.050 |
Why?
|
| Chromatin | 3 | 2016 | 396 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2005 | 358 | 0.050 |
Why?
|
| Leukopoiesis | 1 | 2002 | 3 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2005 | 342 | 0.050 |
Why?
|
| Dinoprostone | 1 | 2002 | 70 | 0.050 |
Why?
|
| Middle Aged | 3 | 2018 | 25649 | 0.050 |
Why?
|
| Sulfur | 1 | 2021 | 29 | 0.050 |
Why?
|
| T-Lymphocytes | 2 | 2002 | 1220 | 0.050 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2001 | 17 | 0.050 |
Why?
|
| Binding Sites | 1 | 2004 | 1113 | 0.050 |
Why?
|
| Iron | 1 | 2021 | 166 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 4 | 2009 | 1056 | 0.050 |
Why?
|
| Bone Development | 1 | 2000 | 35 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2012 | 884 | 0.050 |
Why?
|
| Leukosialin | 1 | 2000 | 16 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 1 | 2000 | 112 | 0.050 |
Why?
|
| Bromodeoxyuridine | 1 | 2000 | 57 | 0.050 |
Why?
|
| Sialoglycoproteins | 1 | 2000 | 31 | 0.040 |
Why?
|
| Adult | 2 | 2018 | 26303 | 0.040 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2000 | 95 | 0.040 |
Why?
|
| DNA Damage | 1 | 2021 | 371 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 3 | 2010 | 956 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 1999 | 80 | 0.040 |
Why?
|
| Colony-Forming Units Assay | 2 | 2000 | 40 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 2010 | 523 | 0.040 |
Why?
|
| Adipose Tissue | 2 | 1992 | 254 | 0.040 |
Why?
|
| Oncogenes | 1 | 1998 | 92 | 0.040 |
Why?
|
| Mitochondria | 1 | 2021 | 548 | 0.040 |
Why?
|
| Sex Factors | 2 | 2012 | 1063 | 0.040 |
Why?
|
| Steroids | 2 | 2013 | 175 | 0.040 |
Why?
|
| Radiation Chimera | 2 | 2010 | 23 | 0.040 |
Why?
|
| Coculture Techniques | 2 | 2009 | 172 | 0.030 |
Why?
|
| Connective Tissue | 1 | 1996 | 23 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2001 | 562 | 0.030 |
Why?
|
| Immunophenotyping | 2 | 2009 | 217 | 0.030 |
Why?
|
| Regeneration | 1 | 2016 | 150 | 0.030 |
Why?
|
| Lipoprotein Lipase | 2 | 1992 | 14 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2009 | 698 | 0.030 |
Why?
|
| Integrins | 1 | 1994 | 78 | 0.030 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 3 | 2001 | 20 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 464 | 0.030 |
Why?
|
| Rats | 4 | 2010 | 4034 | 0.030 |
Why?
|
| Adiponectin | 2 | 2003 | 23 | 0.030 |
Why?
|
| Mice, Inbred NOD | 2 | 2005 | 194 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2005 | 354 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 1993 | 57 | 0.030 |
Why?
|
| Estradiol | 1 | 1993 | 251 | 0.030 |
Why?
|
| Testosterone | 1 | 1994 | 275 | 0.030 |
Why?
|
| Arthritis, Experimental | 1 | 2012 | 26 | 0.030 |
Why?
|
| Growth Inhibitors | 2 | 2003 | 42 | 0.030 |
Why?
|
| Age Factors | 2 | 2010 | 1860 | 0.030 |
Why?
|
| Aging | 1 | 2016 | 710 | 0.030 |
Why?
|
| Fetal Blood | 2 | 2002 | 90 | 0.020 |
Why?
|
| Recombination, Genetic | 2 | 2005 | 441 | 0.020 |
Why?
|
| Mice, SCID | 2 | 2002 | 261 | 0.020 |
Why?
|
| Cell Line, Transformed | 2 | 2002 | 155 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2012 | 226 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 1993 | 451 | 0.020 |
Why?
|
| Phenotype | 2 | 2012 | 2434 | 0.020 |
Why?
|
| Transplantation, Heterologous | 2 | 2002 | 371 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 1991 | 166 | 0.020 |
Why?
|
| Models, Biological | 3 | 2005 | 1764 | 0.020 |
Why?
|
| Environment | 1 | 2012 | 224 | 0.020 |
Why?
|
| Castration | 1 | 2010 | 41 | 0.020 |
Why?
|
| Molecular Sequence Data | 4 | 2000 | 3029 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 80 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2005 | 927 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 1990 | 103 | 0.020 |
Why?
|
| Receptors, Transferrin | 1 | 2009 | 11 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 1990 | 141 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 1992 | 511 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 123 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2010 | 354 | 0.020 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1989 | 47 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 1992 | 539 | 0.020 |
Why?
|
| Reaction Time | 1 | 2010 | 311 | 0.020 |
Why?
|
| Cell Communication | 1 | 2009 | 198 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2010 | 329 | 0.020 |
Why?
|
| Clone Cells | 3 | 1995 | 214 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2008 | 5 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 2000 | 2062 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 340 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 2000 | 392 | 0.020 |
Why?
|
| Immunoglobulin Light Chains | 2 | 2002 | 86 | 0.020 |
Why?
|
| Cell Adhesion | 3 | 1996 | 425 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 1236 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2010 | 464 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2009 | 729 | 0.020 |
Why?
|
| Immunoglobulin mu-Chains | 2 | 2000 | 18 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2008 | 519 | 0.020 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2005 | 19 | 0.020 |
Why?
|
| STAT5 Transcription Factor | 1 | 2005 | 43 | 0.020 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2005 | 37 | 0.020 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2005 | 32 | 0.020 |
Why?
|
| Receptors, Cytokine | 1 | 2005 | 28 | 0.020 |
Why?
|
| Genes, bcl-2 | 1 | 2005 | 16 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 139 | 0.020 |
Why?
|
| Hormone Antagonists | 1 | 2005 | 19 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2005 | 136 | 0.020 |
Why?
|
| Mifepristone | 1 | 2005 | 33 | 0.020 |
Why?
|
| Dealkylation | 1 | 2004 | 3 | 0.020 |
Why?
|
| Disease Progression | 1 | 2009 | 1489 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2005 | 92 | 0.020 |
Why?
|
| CD79 Antigens | 1 | 2004 | 17 | 0.020 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2004 | 55 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2005 | 159 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 1982 | 0.010 |
Why?
|
| Myelopoiesis | 1 | 2003 | 10 | 0.010 |
Why?
|
| Prostaglandins | 1 | 2003 | 42 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 427 | 0.010 |
Why?
|
| Pre-B Cell Receptors | 1 | 2003 | 8 | 0.010 |
Why?
|
| Histones | 1 | 2005 | 327 | 0.010 |
Why?
|
| Antigens, CD7 | 1 | 2002 | 2 | 0.010 |
Why?
|
| Interferon Regulatory Factors | 1 | 2003 | 67 | 0.010 |
Why?
|
| Neprilysin | 1 | 2002 | 41 | 0.010 |
Why?
|
| Precipitin Tests | 2 | 1994 | 111 | 0.010 |
Why?
|
| Centromere | 1 | 2002 | 26 | 0.010 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2002 | 39 | 0.010 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2002 | 33 | 0.010 |
Why?
|
| Heterochromatin | 1 | 2002 | 22 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2002 | 97 | 0.010 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2002 | 42 | 0.010 |
Why?
|
| Hormones | 1 | 2002 | 141 | 0.010 |
Why?
|
| Paracrine Communication | 1 | 2002 | 32 | 0.010 |
Why?
|
| Thiophenes | 1 | 2002 | 43 | 0.010 |
Why?
|
| Nuclear Envelope | 1 | 2002 | 38 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2002 | 99 | 0.010 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2002 | 96 | 0.010 |
Why?
|
| CD5 Antigens | 1 | 2001 | 14 | 0.010 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2001 | 20 | 0.010 |
Why?
|
| Adipose Tissue, Brown | 1 | 2002 | 86 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2001 | 77 | 0.010 |
Why?
|
| Complement Factor D | 2 | 1992 | 3 | 0.010 |
Why?
|
| Macrophage Colony-Stimulating Factor | 2 | 1992 | 18 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2003 | 391 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2002 | 272 | 0.010 |
Why?
|
| Kyphosis | 1 | 2000 | 14 | 0.010 |
Why?
|
| Fluoresceins | 1 | 2000 | 43 | 0.010 |
Why?
|
| Serine Endopeptidases | 2 | 1992 | 146 | 0.010 |
Why?
|
| Tibia | 1 | 2000 | 77 | 0.010 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2000 | 19 | 0.010 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2000 | 20 | 0.010 |
Why?
|
| Receptors, Interferon | 1 | 2000 | 31 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2000 | 307 | 0.010 |
Why?
|
| Models, Animal | 1 | 2001 | 276 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 1020 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 2000 | 150 | 0.010 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 1999 | 11 | 0.010 |
Why?
|
| Bone Density | 1 | 2000 | 209 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2001 | 508 | 0.010 |
Why?
|
| Interferon Type I | 1 | 2000 | 177 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 647 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2000 | 260 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2000 | 275 | 0.010 |
Why?
|
| Radiography | 1 | 2000 | 806 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1998 | 72 | 0.010 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 1998 | 21 | 0.010 |
Why?
|
| Hyaluronan Receptors | 1 | 1998 | 38 | 0.010 |
Why?
|
| Graft Survival | 1 | 2001 | 912 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1996 | 28 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1996 | 23 | 0.010 |
Why?
|
| Base Sequence | 1 | 2000 | 2331 | 0.010 |
Why?
|
| Gene Library | 1 | 1996 | 133 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2001 | 1427 | 0.010 |
Why?
|
| Hybridomas | 1 | 1994 | 75 | 0.010 |
Why?
|
| Integrin beta1 | 1 | 1994 | 33 | 0.010 |
Why?
|
| Antibody Affinity | 1 | 1994 | 38 | 0.010 |
Why?
|
| Glycosylation | 1 | 1994 | 129 | 0.010 |
Why?
|
| Lymphoma | 1 | 1996 | 264 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1994 | 306 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 1995 | 386 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2000 | 2343 | 0.010 |
Why?
|
| Fatty Acid-Binding Protein 7 | 1 | 1992 | 1 | 0.010 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 1992 | 9 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1994 | 797 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1992 | 35 | 0.010 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 1992 | 26 | 0.010 |
Why?
|
| Biomarkers | 1 | 1999 | 1757 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1992 | 244 | 0.010 |
Why?
|
| Culture Media | 1 | 1992 | 147 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1992 | 259 | 0.010 |
Why?
|
| DNA | 1 | 1998 | 1308 | 0.010 |
Why?
|
| Receptors, Very Late Antigen | 1 | 1991 | 6 | 0.010 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1996 | 432 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 1993 | 260 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 1991 | 56 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1992 | 478 | 0.010 |
Why?
|
| Immunoglobulin Light Chains, Surrogate | 1 | 1991 | 4 | 0.010 |
Why?
|
| Proto-Oncogenes | 1 | 1991 | 61 | 0.010 |
Why?
|
| Colony-Stimulating Factors | 1 | 1990 | 14 | 0.010 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1990 | 11 | 0.010 |
Why?
|
| Angiotensinogen | 1 | 1990 | 5 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1990 | 18 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 1996 | 631 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1990 | 130 | 0.010 |
Why?
|
| Immunocompromised Host | 1 | 1991 | 143 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 1990 | 129 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 1991 | 269 | 0.010 |
Why?
|
| Biological Factors | 1 | 1989 | 18 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1992 | 679 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 1990 | 199 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1991 | 447 | 0.000 |
Why?
|
| Nuclear Proteins | 1 | 1992 | 727 | 0.000 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1990 | 280 | 0.000 |
Why?
|
| In Vitro Techniques | 1 | 1989 | 995 | 0.000 |
Why?
|
| Lymph Nodes | 1 | 1990 | 547 | 0.000 |
Why?
|